Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Ben & Jerry's Wants to Get in on CBD Craze
By Tony Owusu
May 30, 2019 4:18 PM EDT
PRESS RELEASES
Corbus Pharmaceuticals To Present At The Jefferies Virtual London Healthcare Conference
By GlobeNewswire
Nov 12, 2020 8:05 AM EST
PRESS RELEASES
Corbus Pharmaceuticals To Report Third Quarter Results On November 10, 2020
By GlobeNewswire
Nov 3, 2020 8:05 AM EST
STOCKS
Ben & Jerry's Wants to Get in on CBD Craze
By Tony Owusu
May 30, 2019 4:18 PM EDT
JIM CRAMER
Real-Deal Rally: Cramer's 'Mad Money' Recap
By Scott Rutt
Oct 24, 2018 11:04 PM EDT
INVESTING
How to Invest in America's Legal Weed Trend Through Marijuana Stocks
By Stephen Guilfoyle
Jan 2, 2018 8:19 AM EST
INVESTING
Did Corbus Investors Get Thrown Off by a Red Herring?
By Chiradeep BasuMallick
Apr 10, 2017 3:51 PM EDT
JIM CRAMER
Home Depot, Federal Realty, more: 'Mad Money' Lightning Round
By Bret Kenwell
Apr 8, 2017 6:35 AM EDT
JIM CRAMER
Market Stays Strong in the Fight: Cramer's 'Mad Money' Recap
By Bret Kenwell
Apr 8, 2017 6:25 AM EDT
JIM CRAMER
Taser, AMD, Amgen, Old Republic :'Mad Money' Lightning Round (3/30/17)
By Bret Kenwell
Mar 31, 2017 6:32 AM EDT
JIM CRAMER
Busting the Shorts : Cramer's 'Mad Money' Recap
By Bret Kenwell
Mar 31, 2017 6:22 AM EDT
STOCKS
Corbus Pharma Drug Shows No Clinical Benefit for Cystic Fibrosis Patients
By Adam Feuerstein
Mar 30, 2017 8:30 PM EDT
STOCKS
Corbus Pharmaceuticals looks to be a winner, while Pershing Gold requires patience
By Bruce Kamich
Dec 28, 2016 12:22 PM EST
STOCKS
Here are 4 somewhat risky stocks that may deliver explosive gains
By Chiradeep BasuMallick
Dec 28, 2016 8:50 AM EST
STOCKS
What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
By Adam Feuerstein
Dec 22, 2016 11:20 AM EST
STOCKS
Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals
By Scott Rutt
Nov 23, 2016 6:00 AM EST
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Expect More Earnings Surprises
By Scott Rutt
Nov 22, 2016 8:22 PM EST
STOCKS
Corbus Pharma bear thesis is alive and well
By Adam Feuerstein
Nov 15, 2016 6:55 AM EST
OPINION
Jim Cramer: Corbus Pharma shows the upside of biotech risk
By Bret Kenwell
Nov 14, 2016 10:39 AM EST
JIM CRAMER
'Mad Money' Lightning Round: Smith and Wesson Represents Value, Cramer Says
By Scott Rutt
Oct 29, 2016 9:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: How Powerful Are GE, Royal Dutch Shell and Occidental?
By Scott Rutt
Oct 28, 2016 8:30 PM EDT
STOCKS
Bear thesis on Corbus Pharma could cause a crash landing for high-flying biotech stock
By Adam Feuerstein
Oct 25, 2016 8:44 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Politics and Your Portfolio
By Bret Kenwell
Oct 19, 2016 8:53 PM EDT
MARKETS
Corbus pharmaceuticals (crbp) stock closed sharply higher, cantor fitzgerald initiates coverage
By Rachel Aldrich
Oct 5, 2016 4:03 PM EDT
OPINION
Corbus CEO on Resunab and the pharma's unstoppable stock
By Gregg Greenberg
Sep 23, 2016 3:59 PM EDT
